ACADIA Pharmaceuticals
ACAD
#3702
Rank
ยฃ2.18 B
Marketcap
ยฃ13.12
Share price
-2.70%
Change (1 day)
-29.37%
Change (1 year)

Revenue for ACADIA Pharmaceuticals (ACAD)

Revenue in 2024 (TTM): ยฃ0.70 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.70 Billion. In 2023 the company made a revenue of ยฃ0.57 Billion an increase over the revenue in the year 2022 that were of ยฃ0.42 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ACADIA Pharmaceuticals from 2003 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.70 B24.37%
2023 ยฃ0.57 B33.37%
2022 ยฃ0.42 B19.2%
2021 ยฃ0.35 B10.67%
2020 ยฃ0.32 B25.33%
2019 ยฃ0.25 B46.66%
2018 ยฃ0.17 B90.78%
2017 ยฃ92.41 M557.97%
2016 ยฃ14.04 M34022.19%
2015 ยฃ0.04 M-47.04%
2014 ยฃ0.07 M-88.8%
2013 ยฃ0.69 M-77.14%
2012 ยฃ3.03 M128.29%
2011 ยฃ1.32 M-95.13%
2010 ยฃ27.29 M590.34%
2009 ยฃ3.95 M264.45%
2008 ยฃ1.08 M-71.47%
2007 ยฃ3.8 M-8.42%
2006 ยฃ4.15 M-34.64%
2005 ยฃ6.35 M164.91%
2004 ยฃ2.39 M-45.14%
2003 ยฃ4.37 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.14 B-79.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.06 B 6,148.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.36 B 4,488.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ69.45 B 9,747.57%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ37.56 B 5,226.58%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ69.84 M-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA